CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors
Over half of breast-cancer-related deaths are due to recurrence 5 or more years after initial diagnosis and treatment. This latency suggests that a population of residual tumor cells can survive treatment and persist in a dormant state for many years. The role of the microenvironment in regulating t...
| Published in: | eLife |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
eLife Sciences Publications Ltd
2019-04-01
|
| Subjects: | |
| Online Access: | https://elifesciences.org/articles/43653 |